2010-12-24 |
InCCNM -I |
CIGB |
Registered |
2008-09-19 |
Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba. |
FINLAY |
Registered |
2010-12-27 |
Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III. |
CIM |
Registered |
2008-07-29 |
A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers. |
FINLAY |
Registered |
2008-07-29 |
Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age. |
FINLAY |
Registered |
2010-12-17 |
Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I. |
CIM |
Registered |
2008-07-29 |
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET. |
FINLAY |
Registered |
2008-07-29 |
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine. |
FINLAY |
Registered |
2009-02-26 |
CITOPROT-III |
CIGB |
Registered |
2010-12-24 |
Application of CIGB-128 in keloid patients undergoing surgical exeresis. |
CIGB |
Registered |
2010-12-24 |
CIGB-128 administration to patients with surgically-treated keloids. |
CIGB |
Registered |
2010-12-27 |
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed |
CIGB |
Registered |
2008-09-18 |
Tisuacryl® in Dental Hyperesthesia |
BIOMAT |
Registered |
2008-10-16 |
FASECU I |
CIGB |
Registered |
2010-12-28 |
InCarbacel-II |
CIGB |
Registered |
2009-02-11 |
Recombinant interferon alpha-2b in paranoid schizophrenia. |
CIGB |
Registered |
2010-12-17 |
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II |
CIM |
Registered |
2010-12-17 |
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II |
CIM |
Registered |
2010-12-17 |
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. |
CIM |
Registered |
2010-12-17 |
Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors. |
CIM |
Registered |